Ipratropium bromide nasal solution, 0.03% is supplied in a white high density polyethylene (HDPE) bottle fitted with a metered nasal spray pump, a green safety clip to prevent accidental discharge of the spray, and a clear plastic dust cap (NDC 60505-0826-1). It contains 31.1g of product formulation, 345 sprays, each delivering 21 mcg (70 mcL) of ipratropium bromide per spray, or 28 days of therapy at the maximum recommended dose (two sprays per nostril three times a day).
Store tightly closed at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature]. Avoid freezing. Keep out of reach of children. Do not spray in the eyes.
Avoid freezing. Keep out of reach of children. Do not spray in the eyes.
Patients should be reminded to read and follow the accompanying “Patient’s Instructions for Use”, which should be dispensed with the product.
Manufactured by: Manufactured for:
Apotex Inc. Apotex Corp.
Toronto, Ontario Weston, FL
Canada M9L 1T9 33326